[1]
E. Phillips, MPH and J. Gazmararian, PhD, MPH, “Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality”, J of Opioid Management, vol. 13, no. 4, pp. 229–239, Jul. 2017.